Zhejiang Cheng Yi Pharmaceutical Co., Ltd. (603811.SS)
CNY 9.05
(6.1%)
CNY 9.05
(6.1%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 696.15 Million CNY | 10.82% |
| 2022 | 628.16 Million CNY | 94.11% |
| 2021 | 323.61 Million CNY | 0.88% |
| 2020 | 320.79 Million CNY | 51.83% |
| 2019 | 211.28 Million CNY | 48.33% |
| 2018 | 142.44 Million CNY | 94.04% |
| 2017 | 73.41 Million CNY | -12.72% |
| 2016 | 84.1 Million CNY | -2.44% |
| 2015 | 86.21 Million CNY | 4.16% |
| 2014 | 82.76 Million CNY | -37.5% |
| 2013 | 132.43 Million CNY | -26.42% |
| 2012 | 179.99 Million CNY | -6.78% |
| 2011 | 193.08 Million CNY | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q1 | 647.94 Million CNY | -6.93% |
| 2024 Q3 | 569.2 Million CNY | 0.11% |
| 2024 Q2 | 568.55 Million CNY | -12.25% |
| 2023 Q4 | 696.15 Million CNY | 1.49% |
| 2023 FY | 696.15 Million CNY | 10.82% |
| 2023 Q3 | 685.91 Million CNY | 2.94% |
| 2023 Q1 | 685.16 Million CNY | 9.07% |
| 2023 Q2 | 666.31 Million CNY | -2.75% |
| 2022 Q4 | 628.16 Million CNY | 11.29% |
| 2022 Q1 | 368.37 Million CNY | 13.83% |
| 2022 Q2 | 542.17 Million CNY | 47.18% |
| 2022 FY | 628.16 Million CNY | 94.11% |
| 2022 Q3 | 564.43 Million CNY | 4.11% |
| 2021 Q3 | 295.18 Million CNY | -10.9% |
| 2021 FY | 323.61 Million CNY | 0.88% |
| 2021 Q1 | 295.11 Million CNY | -8.0% |
| 2021 Q2 | 331.29 Million CNY | 12.26% |
| 2021 Q4 | 323.61 Million CNY | 9.63% |
| 2020 FY | 320.79 Million CNY | 51.83% |
| 2020 Q1 | 183.42 Million CNY | -13.19% |
| 2020 Q2 | 443.77 Million CNY | 141.94% |
| 2020 Q3 | 398.09 Million CNY | -10.29% |
| 2020 Q4 | 320.79 Million CNY | -19.42% |
| 2019 FY | 211.28 Million CNY | 48.33% |
| 2019 Q2 | 166.66 Million CNY | 30.82% |
| 2019 Q1 | 127.4 Million CNY | -10.56% |
| 2019 Q3 | 200.3 Million CNY | 20.18% |
| 2019 Q4 | 211.28 Million CNY | 5.48% |
| 2018 Q1 | 86.66 Million CNY | 18.05% |
| 2018 FY | 142.44 Million CNY | 94.04% |
| 2018 Q4 | 142.44 Million CNY | 18.66% |
| 2018 Q3 | 120.04 Million CNY | 16.18% |
| 2018 Q2 | 103.32 Million CNY | 19.23% |
| 2017 Q3 | 55.18 Million CNY | 6.98% |
| 2017 FY | 73.41 Million CNY | -12.72% |
| 2017 Q4 | 73.41 Million CNY | 33.02% |
| 2017 Q1 | 59.52 Million CNY | -29.23% |
| 2017 Q2 | 51.58 Million CNY | -13.33% |
| 2016 Q2 | 84.5 Million CNY | 0.0% |
| 2016 FY | 84.1 Million CNY | -2.44% |
| 2016 Q4 | 84.1 Million CNY | 0.0% |
| 2016 Q1 | - CNY | 0.0% |
| 2015 FY | 86.21 Million CNY | 4.16% |
| 2014 Q1 | 129.57 Million CNY | 0.0% |
| 2014 Q2 | 129.57 Million CNY | 0.0% |
| 2014 Q4 | 82.76 Million CNY | 0.0% |
| 2014 FY | 82.76 Million CNY | -37.5% |
| 2013 FY | 132.43 Million CNY | -26.42% |
| 2012 FY | 179.99 Million CNY | -6.78% |
| 2011 FY | 193.08 Million CNY | 0.0% |